Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.
about
Bortezomib for the treatment of multiple myelomaReview of health-related quality of life data in multiple myeloma patients treated with novel agents.The Value of Patient Reported Outcomes and Other Patient-Generated Health Data in Clinical Hematology.Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: results of a randomized trial.Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide.Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials.Quality of life and supportive care in multiple myeloma.Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort studyProspective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment.Optimizing quality of life in multiple myeloma patients: current options, challenges and recommendations.Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.A systematic review of health-related quality of life in longitudinal studies of myeloma patients.Management of multiple myeloma in older adults: Gaining ground with geriatric assessment.Management of Elderly Patients with Plasma Cell Myeloma.Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry.Health-Related Quality of Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.Multiple myeloma: an update.Acute lymphoblastic leukemia developing during maintenance therapy with lenalidomide in a patient with multiple myeloma.Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
P2860
Q24185881-CFDFB388-6E0D-437D-8171-CC527B86E5A7Q30650394-D12F99D6-DE46-45B0-A1A9-E463A0093AC4Q30964688-5671F224-0848-4811-8777-B2568D051B09Q33557934-9753E770-C0C5-4558-98D7-17FBD3D9B162Q34049802-3F0DB830-3534-4E4F-BE56-8B18A7EBA1F7Q35669893-AA213289-1473-4692-8A0C-8B30021064ABQ37057028-CC3AB6EC-80B0-4C6B-B22E-07E0474B0864Q37384918-F04E9C80-8F0D-4942-BC26-92F0F4CFDDB0Q37426566-7B5B3417-AD7F-437E-AFAA-D72ED14D571AQ37440614-EC52B89A-4820-474A-9F14-DA6A10350313Q37737797-452819AE-75F7-4E7B-916C-1CED07FB7AA0Q38367654-554DAE47-24D3-440F-956E-0D0856414CB7Q38459634-5444D6CD-5A8B-4CCD-AABE-3E228CC35FEBQ38742505-62DA26B5-6279-4815-805D-1F0B6963D41AQ38818674-10D1DDA0-52D9-46CB-AD40-FEBA88C772D5Q39001325-60F7B782-4948-40A2-9939-A45D2253AF9DQ39084538-4098DC36-E717-4F89-A9AD-0AC48D22E723Q39416134-A2C5C389-FBCE-44E7-A023-7B6A10B6DCC0Q39471739-FE570668-E924-4038-B187-7018B534E98EQ46252693-6DE77E0C-F6BC-47BB-8C38-24501834D0BBQ48056468-B69C7406-B3AC-4CB9-8DD3-0DD58F424FEC
P2860
Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Health-related quality of life ...... results from the VISTA trial.
@en
Health-related quality of life ...... results from the VISTA trial.
@nl
type
label
Health-related quality of life ...... results from the VISTA trial.
@en
Health-related quality of life ...... results from the VISTA trial.
@nl
prefLabel
Health-related quality of life ...... results from the VISTA trial.
@en
Health-related quality of life ...... results from the VISTA trial.
@nl
P2093
P2860
P1476
Health-related quality of life ...... : results from the VISTA trial
@en
P2093
Andrew Cakana
Antoine Regnault
Dixie-Lee Esseltine
Don Robinson
Helgi van de Velde
Juliette Meunier
Michel Delforge
Ravinder Dhawan
P2860
P356
10.1111/J.1600-0609.2012.01788.X
P577
2012-05-07T00:00:00Z